Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Inspire Medical Systems Inc (NYSE: INSP) closed at $77.04 down -1.90% from its previous closing price of $78.53. In other words, the price has decreased by -$1.90 from its previous closing price. On the day, 0.93 million shares were traded. INSP stock price reached its highest trading level at $79.22 during the session, while it also had its lowest trading level at $76.83.
Ratios:
For a deeper understanding of Inspire Medical Systems Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.80. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 6.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On September 02, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $150. Truist Downgraded its Buy to Hold on August 05, 2025, while the target price for the stock was maintained at $125.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 29 ’25 when Buchholz Richard sold 11,000 shares for $93.39 per share. The transaction valued at 1,027,290 led to the insider holds 44,867 shares of the business.
Buchholz Richard bought 11,000 shares of INSP for $1,027,349 on Aug 29 ’25. On May 19 ’25, another insider, Rondoni John, who serves as the insider of the company, sold 1,734 shares for $149.38 each. As a result, the insider received 259,025 and left with 13,766 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 2278405376 and an Enterprise Value of 2054635008. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 44.63, and their Forward P/E ratio for the next fiscal year is 49.94. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.08. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.65 while its Price-to-Book (P/B) ratio in mrq is 3.36. Its current Enterprise Value per Revenue stands at 2.385 whereas that against EBITDA is 39.371.
Stock Price History:
The Beta on a monthly basis for INSP is 1.17, which has changed by -0.6303618 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $218.52, while it has fallen to a 52-week low of $73.92. The 50-Day Moving Average of the stock is -21.60%, while the 200-Day Moving Average is calculated to be -47.83%.
Shares Statistics:
For the past three months, INSP has traded an average of 1.07M shares per day and 1103010 over the past ten days. A total of 29.57M shares are outstanding, with a floating share count of 26.73M. Insiders hold about 9.62% of the company’s shares, while institutions hold 106.65% stake in the company. Shares short for INSP as of 1756425600 were 2347878 with a Short Ratio of 2.20, compared to 1753920000 on 2511665. Therefore, it implies a Short% of Shares Outstanding of 2347878 and a Short% of Float of 10.66.
Earnings Estimates
A detailed examination of Inspire Medical Systems Inc (INSP) is currently in progress, with 10.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.67, with high estimates of $0.74 and low estimates of $0.55.
Analysts are recommending an EPS of between $1.08 and $0.5 for the fiscal current year, implying an average EPS of $0.99. EPS for the following year is $1.64, with 12.0 analysts recommending between $2.88 and $0.94.
Revenue Estimates
A total of 17 analysts believe the company’s revenue will be $220.39M this quarter.It ranges from a high estimate of $222.7M to a low estimate of $210.41M. As of the current estimate, Inspire Medical Systems Inc’s year-ago sales were $203.19MFor the next quarter, 17 analysts are estimating revenue of $264.95M. There is a high estimate of $271.2M for the next quarter, whereas the lowest estimate is $261.4M.
A total of 18 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $905.64M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $903.79M. In the same quarter a year ago, actual revenue was $802.8MBased on 18 analysts’ estimates, the company’s revenue will be $1.03B in the next fiscal year. The high estimate is $1.07B and the low estimate is $1.01B.
